PubRank

Douglas S Reintgen

Author PubWeight™ 83.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006 15.64
2 gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med 2011 5.15
3 Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 2007 4.05
4 Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005 3.80
5 The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol 2010 3.02
6 Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006 2.69
7 Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol 2008 2.51
8 Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 2011 2.28
9 An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004 2.18
10 Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004 2.18
11 Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol 2006 2.00
12 Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol 2012 1.92
13 Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 2006 1.85
14 Current status of sentinel lymph node mapping and biopsy: facts and controversies. Oncologist 2003 1.74
15 Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2002 1.62
16 Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer 2010 1.53
17 Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003 1.52
18 Prevalence of additional positive lymph nodes in complete lymphadenectomy specimens after positive sentinel lymphadenectomy findings for early-stage melanoma of the head and neck. Plast Reconstr Surg 2003 1.45
19 New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 2003 1.34
20 Interval sentinel lymph nodes in melanoma. Arch Surg 2002 1.32
21 Gender-related differences in outcome for melanoma patients. Ann Surg 2006 1.32
22 Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J 2002 1.18
23 Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol 2004 1.15
24 Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol 2009 1.08
25 Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 2002 1.02
26 The new melanoma staging system. Cancer Control 2002 1.01
27 Molecular mechanisms of metastasis. Cancer Metastasis Rev 2006 1.00
28 Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. Ann Surg 2010 0.96
29 Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 2003 0.96
30 Is incisional biopsy of melanoma harmful? Am J Surg 2005 0.94
31 Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database. Cancer Control 2006 0.92
32 Second primary melanomas: incidence and outcome. Am Surg 2010 0.92
33 Metastatic melanoma: chemotherapy to biochemotherapy. Cancer Control 2002 0.91
34 Immunotherapy for melanoma. Cancer Control 2002 0.91
35 The prognostic significance of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2010 0.88
36 Prognostic information from sentinel lymph node biopsy in patients with thick melanoma. Arch Surg 2010 0.87
37 Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg 2002 0.86
38 The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node. Ann Surg Oncol 2009 0.84
39 Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010. Ann Surg Oncol 2010 0.84
40 The promise of microarray technology in melanoma care. Cancer Control 2002 0.82
41 Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mapping. Plast Reconstr Surg 2004 0.81
42 Full-thickness grafts procured from skin overlying the sentinel lymph node basin; reconstruction of primary cutaneous malignancy excision defects. Ann Surg Oncol 2008 0.79
43 Diversity of stage III melanoma in the era of sentinel lymph node biopsy. Ann Surg Oncol 2012 0.79
44 Worldwide experience with lymphatic mapping for invasive breast cancer. Semin Oncol 2004 0.79
45 Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up. Ann Surg Oncol 2010 0.79
46 Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. J Surg Res 2007 0.78
47 Regional node dissection for melanoma: techniques and indication. Surg Oncol Clin N Am 2007 0.77
48 Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up. Ann Surg Oncol 2009 0.77
49 Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. J Am Acad Dermatol 2003 0.75
50 Effect of lymphatic mapping on diagnosis and treatment of patients with T1a, T1b favorable breast cancer. Ann Surg 2003 0.75
51 Accurate staging of women with breast cancer. J Surg Oncol 2002 0.75
52 Superficial femoral lymph node dissection after positive sentinel lymphadenectomy for early-stage melanoma of the lower extremity. Ann Plast Surg 2003 0.75
53 A case report of invasive ductal adenocarcinoma identified in a lymphatic channel: a staging controversy. Cancer Control 2003 0.75
54 The promise of new technologies and therapies. Cancer Control 2002 0.75
55 The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy. Cancer Control 2004 0.75